CDK1 and pulmonary arterial hypertension: PAH affected the molecules that regulate Drp1 activity, such as the increase in PINK1 and CDK1/Cyclin B, prompting Drp1 to be more active (Marsboom et al., 2012; Linqing et al., 2021).